Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UTP6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CYP2D6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AMPD3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TRRAP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TRIM72 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NCF4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | DBP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TGM6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RC3H2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |